ÅǸ޴º
¹øÈ£ | ±¸ºÐ | Á¦¸ñ |
---|---|---|
257 | (±¹¿Ü)SCIE | Vascular enhancement pattern of mass in computed tomography may predict chemo-responsiveness in advanced pancreatic cancer |
256 | (±¹¿Ü)SCI | Fecal calprotectin as a non-invasive biomarker for intestinal involvement of Beh?t's disease |
255 | (±¹¿Ü)SCIE | Does a Pre-Training Program Influence Colonoscopy Proficiency during Fellowship? |
254 | (±¹¿Ü)SCI | Clinical response to dorsal duct drainage via the minor papilla in refractory obstructing chronic calcific pancreatitis |
253 | (±¹¿Ü)SCIE | Tumor characteristics associated with malignant large bowel obstruction in stage IV colorectal cancer patients undergoing chemotherapy |
252 | (±¹¿Ü)SCIE | Variation in the Dicer and RAN Genes Are Associated with Survival in Patients with Hepatocellular Carcinoma |
251 | (±¹¿Ü)SCIE | Clinical outcomes and predictors for relapse after cessation of oral antiviral treatment in chronic hepatitis B patients. |
250 | (±¹¿Ü)SCIE | Suppressed Helicobacter pylori-associated gastric tumorigenesis in Fat-1 transgenic mice producing endogenous ¥ø-3 polyunsaturated fatty acids. |
249 | (±¹³»)SCOPUS | ¾Ï¼ºÇ÷ÀüÀ» µ¿¹ÝÇÑ Ä§À±¼º °£¾ÏÀ¸·Î ¿ÀÁøµÈ ¹®¸Æ¿°À¸·Î ÀÎÇÑ ±Þ¼º °£°æ»ö |
248 | (±¹¿Ü)SCIE | Role of transarterial chemoembolization in relation with sorafenib for patients with advanced hepatocellular carcinoma |
Copyright ¨Ï chamc, All rights reserved.